Publications

Li, W., C. L. Wu, P. G. Febbo, and A. F. Olumi. 2007. Stromally Expressed C-Jun Regulates Proliferation of Prostate Epithelial Cells.

Li, W., X. Zhang, and A. F. Olumi. 2007. MG-132 Sensitizes TRAIL-Resistant Prostate Cancer Cells by Activating C-Fos/C-Jun Heterodimers and Repressing C-FLIP(L).

Yang, H., Y. A. Minamishima, Q. Yan, S. Schlisio, B. L. Ebert, X. Zhang, L. Zhang, W . Y. Kim, A. F. Olumi, and W. G. Kaelin Jr. 2007. PVHL Acts As an Adaptor to Promote the Inhibitory Phosphorylation of the NF-KappaB Agonist Card9 by CK2.

Halperin, T. J., S. A. Slavin, A. F. Olumi, and L. J. Borud. 2007. Surgical Management of Scrotal Lymphedema Using Local Flaps.

Huang, X., X. Zhang, B. Farahvash, and A. F. Olumi. 2007. Novel Targeted Pro-Apoptotic Agents for the Treatment of Prostate Cancer.

Li, L., L. Zhang, X. Zhang, Q. Yan, Y. A. Minamishima, A. F. Olumi, M. Mao, S. Bartz, and W. G. Kaelin Jr. 2007. Hypoxia-Inducible Factor Linked to Differential Kidney Cancer Risk Seen With Type 2A and Type 2B VHL Mutations.

San Francisco, I. F., M. M. Regan, W. C. Dewolf, and A. F. Olumi. 2006. Low Age Adjusted Free Testosterone Levels Correlate With Poorly Differentiated Prostate Cancer.

. Y. Huang, W, A. F. Olumi, and S. Rosen. 2006. Urothelial Mucosal Malformation: A Rare Cause for Ureteropelvic Junction Obstruction.

San Francisco, I. F., M. M. Regan, A. F. Olumi, and W. C. DeWolf. 2004. Percent of Cores Positive for Cancer Is a Better Preoperative Predictor of Cancer Recurrence After Radical Prostatectomy Than Prostate Specific Antigen.

Zhang, X., T. G. Jin, H. Yang, W. C. DeWolf, R. Khosravi-Far, and A. F. Olumi. 2004. Persistent C-FLIP(L) Expression Is Necessary and Sufficient to Maintain Resistance to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Mediated Apoptosis in Prostate Cancer.